Viewing Study NCT00430534


Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2026-02-05 @ 5:43 PM
Study NCT ID: NCT00430534
Status: COMPLETED
Last Update Posted: 2007-02-02
First Post: 2007-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).
Sponsor: Henogen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epstein Barr Virus (EBV) Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Epstein Barr Virus View
None Belgium View
None Infectious mononucleosis View